PT  - JOURNAL ARTICLE
AU  - Shi, Zhenhao
AU  - Wang, An-Li
AU  - Liu, Jiaying
AU  - Audrain-McGovern, Janet
AU  - Lynch, Kevin G.
AU  - Loughead, James
AU  - Langleben, Daniel D.
TI  - Delayed effects of cigarette graphic warning labels on smoking behavior
AID  - 10.1101/2024.01.06.24300835
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.01.06.24300835
4099  - http://medrxiv.org/content/early/2024/09/26/2024.01.06.24300835.short
4100  - http://medrxiv.org/content/early/2024/09/26/2024.01.06.24300835.full
AB  - Introduction Graphic warning labels (GWLs) are widely employed to communicate smoking-related health risks; however, their implementation in the US has been held back by concerns about their efficacy. Most GWLs elicit a high level of emotional reaction (ER). The extent to which ER contributes to GWLs efficacy in improving smoking outcomes is a subject of debate. Our recent study showed poorer efficacy of the high-ER GWLs versus the low-ER ones during a month-long naturalistic exposure. Whether GWL effects persist after discontinuing the exposure remains unclear.Methods We conducted a secondary analysis to investigate the delayed effects of GWLs on smoking severity in adult smokers. The number of cigarettes smoked per day (CPD) was measured immediately as well as 4 weeks after the end of a month-long exposure to high-ER versus low-ER GWLs. Participants indicated their subjective feeling of being relieved from having to see the GWLs.Results We found a significant reduction in CPD from the immediate to the 4-week post-exposure timepoint. There was no difference in CPD reduction between the high-ER and low-ER groups.Subjective sense of relief from GWL exposure was associated with greater CPD reduction in the high-ER group, but not the low-ER group.Conclusions Our study suggests lasting impact of GWLs on smoking behavior. The findings may be particularly important to high-arousal GWLs, which appear less effective in reducing smoking during active exposure.Implications Whether GWLs that evoke higher ER are more effective remains inconclusive. We recently showed that high-ER GWLs are less effective than low-ER ones in reducing smoking during continuous exposure. Here, we found evidence of delayed GWL effects such that smoking decreased from immediately to four weeks after the end of GWL exposure. Feeling of relief from GWL exposure was associated greater smoking reduction in the high-ER group. We suggest that continuously exposing smokers to high-ER GWLs that have been well remembered may be unnecessary and counterproductive.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) and the Center for Tobacco Products of the Food and Drug Administration (FDA) under award number R01DA036028 (PI: DDL); NIH/NIDA under award number K01DA051709 (PI: ZS); and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the NIH under award number R00HD084746 (PI: ALW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the University of Pennsylvania Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData produced in the present study are available upon reasonable request.